Ionis Pharmaceuticals, Inc. Inventory, Finished Goods, Gross
Ionis Pharmaceuticals, Inc. (IONS) had Inventory, Finished Goods, Gross of $2.12 million as of 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2025-04-30
- 2025-03-31: Inventory, Finished Goods, Gross $2.12M.
- 2024-12-31: Inventory, Finished Goods, Gross $276.00K.
- 2024-09-30: Inventory, Finished Goods, Gross $63.00K.
- 2024-06-30: Inventory, Finished Goods, Gross $486.00K.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2025-03-31 | $2.12M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $276.00K 10-Q · filed 2025-04-30 |
| 2024-09-30 | $63.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $486.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $200.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $154.00K 10-K · filed 2025-02-19 |
| 2023-09-30 | $176.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $196.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $218.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $164.00K 10-K · filed 2024-02-21 |
| 2022-09-30 | $288.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $309.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $466.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $390.00K 10-K · filed 2023-02-22 |
| 2021-09-30 | $607.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.56M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $1.91M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $3.00M 10-K · filed 2022-02-25 |
| 2020-09-30 | $950.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $741.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $602.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $258.00K 10-K · filed 2021-02-24 |
| 2018-12-31 | $85.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |